b.fab GmbH
- Founded in: 2018
- Number of employees: 2
- Country: Germany
- Investors: b.value AG
- Market: Biopolymers, Biosolvents, Bio oils, Feed additives
- Website: www.bfab.bio
Which input provides your business model/core technology towards a bio-based economy?
Our technology enables the establishment of a Formate Bioeconomy and thus, it relieves the bio-based economy from it´s dependency on sugars or plant derived feedstocks. We will set up a bioeconomy on abundant feedstocks suchs as CO2 and water. Through CO2-electrolyzers CO2 is reduced to formate, which is a liquid and is storable. Formate is the feedstock for our bioprocess which can be directed into different products by applying synthetic biology.
Which market/clients do you address and which short-term/long-term goals do you have?
b.fab addresses customers in the chemical, cosmetic and oil industry. We want to provide new economical and sustainable routes to produce chemicals starting from CO2, water and renewable energy. Our goal is to establish a Formate Bioeconomy which is based on artificial photosynthesis and synthetic biology enabling better energy efficiencies in converting solar energy into products. Synthetic pathway design allows us to adapt our cell factories for production of bioplastics, solvents and terpenes.
What makes your approach unique compared to other stakeholders in the field?
b.fab´s bioprocesses are unique in terms of energy efficiency from solar energy to product. At the same time we use liquid, storable C1 feedstocks to feed our bioprocesses and thus, we overcome common mass transfer limitations of gas fermentations. Additionally, b.fab applies aerobic cell factories which can be easily designed, handled and optimized to ensure a fast bioprocess development and industrial implementation.
You can meet b.fab in Toulouse at the START-UP VILLAGE @EFIB on 17-18 October.